Exagen Inc. Common Stock XGN
$8.41
+6.86%
at last close
Financials (TTM)
- Revenue
- $71.12 million
- Net Income
- $-18,923,000
- Net Margin
- -26.61%
- Return on Equity
- -154.90%
- Debt-to-Equity
- 1.87
- P/E Ratio
- —
- Price / Book
- 16.68
- Price / Sales
- 2.86
Over the trailing twelve months, Exagen Inc. Common Stock generated revenue of $71.12 million and net income of $-18,923,000, a net margin of -26.61%.
At the last closing price of $8.41, XGN trades at 2.86 times sales, with a market capitalization of $203.74 million.
Key Stats
- Last Close
- $8.41
- Market Cap
- $203.74 million
- 52-Week Range
- $2.59 – $12.23
- Average Volume
- 288K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.